Last chance to stop Instagram training Meta's AI with your data
Meta's new AI logo is creeping into more areas of its services like WhatsApp. On Instagram, users now have just days until a deadline ends to opt-out of their data being used to train the AI. — Photo: Zacharie Scheurer/dpa
SAN FRANCISCO: On May 27 at the latest, Meta will begin training its new artificial intelligence system, Meta AI, using public data from its users.
Instagram users can object to this, provided they fill out an online form by May 26. You'll need to be logged in and and give your email address.
The additional text field can be left blank, and consumer protection groups have pointed out that no justification is needed for an objection.
Once approved, you should see a pop-up saying "We will honour your request," after which you receive an email confirming that Meta won't use your public information to train its AI.
Consumer protection activists say Meta's approach to AI violates European data protection laws and court claims in the EU are pending. However consumer rights experts suggest users actively opt out nonetheless.
A similar opt-out form is also available for Facebook users, but it requires more information. Personal chats on WhatsApp are not affected by Meta's use of AI. However, if users communicate with Meta AI on WhatsApp or include Meta AI in a group chat, this communication could be used for AI training.
To avoid this, users should refrain from using Meta AI on WhatsApp. This includes not using the Meta AI input field, not tapping the bluish circle, and not adding the AI assistant to a group chat with "@MetaAI."
Meta AI and the blue circle cannot be disabled or hidden in Meta's services. Users who do not wish to use the AI can only ignore it. – dpa
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Malaysian Reserve
an hour ago
- Malaysian Reserve
HIMSS Unites Global Healthcare Leaders to Shape the Future of Care: From Paris to Kuala Lumpur to Las Vegas
ROTTERDAM, Netherlands, June 6, 2025 /PRNewswire/ — Thousands of health and technology leaders will gather to share critical health technology insights to optimize care delivery and improve health outcomes at the 2025 HIMSS European Health Conference & Exhibition from 10-12 June in Paris. HIMSS (the Healthcare Information and Management Systems Society) is a non-profit organization that serves as a global health technology advisor and thought leader dedicated to improving health through information and technology. HIMSS supports health professionals and organizations through education, professional development, networking, and digital maturity assessment tools and advisory services that help transform the global health ecosystem. At HIMSS25 Europe, powerful speakers, hands-on sessions and data-powered case studies will spur dialogue around artificial intelligence, governance, cybersecurity, workforce development, and digital maturity. Following the European conference, all eyes turn to upcoming HIMSS conferences across the globe – the 2025 HIMSS APAC Health Conference & Exhibition in July in Kuala Lumpur; and the 2026 HIMSS Global Health Conference & Exhibition in March 2026 in Las Vegas. HIMSS conferences are part of a global strategy to support healthcare organizations and professionals through a professional society of more than 125,000 members and the HIMSS digital health maturity models – internationally recognized benchmarks to assess and advise health systems in critical areas such as analytics, infrastructure, community care and EMR management. HIMSS25 Europe: Advancing AI, Health Policy and Cybersecurity HIMSS25 Europe will be the epicenter for health professionals from more than 70 countries to explore critical themes: Artificial intelligence: World-class experts will demonstrate how to effectively and ethically utilize AI in healthcare. Regulatory leadership: European officials will dive into the EU AI Act, the Cyber Resilience Act and the European Health Data Space. Cybersecurity: Attendees will learn to respond to cyber threats, safeguard patient data and ensure rapid response to cyber risks. HIMSS25 APAC: Building Momentum HIMSS25 APAC will continue the global dialogue from 16-18 July in Kuala Lumpur. HIMSS partnered with Informa Markets to co-locate its APAC conference within International Healthcare Week 2025, Southeast Asia's premier healthcare event. HIMSS25 APAC will strengthen collaboration across health ministries, private sector leaders, clinicians and technology partners. Hundreds of expert speakers will lead discussions, share solutions, and spark ideas to help shape the future of healthcare. HIMSS26: Global Health Innovation Landing in Las Vegas Co-produced with Informa Markets, the 2026 HIMSS Global Health Conference & Exhibition will convene a diverse group of digital health experts from 9-12 March 2026 in Las Vegas. HIMSS26 will feature expanded AI and cybersecurity pavilions, plus workshops on nursing informatics, workforce development, interoperability, and much more. About HIMSSHIMSS (Healthcare Information and Management Systems Society) is a global advisor, thought leader and member-based society committed to reforming the global health ecosystem through the power of information and technology. As a mission-driven nonprofit, HIMSS offers a unique depth and breadth of expertise in digital health transformation, artificial intelligence, cybersecurity, workforce development, public policy, and research to advise leaders, stakeholders and influencers across the global health ecosystem on best practices. With a community-centric approach, our health innovation experts deliver key insights, education, advisory services, and engaging events to healthcare providers, payers, governments, and other health services organizations, ensuring they have the right information at the point of decision. HIMSS has served the global health community for more than 60 years, with focused operations across Americas, Europe, the United Kingdom, the Middle East and Asia-Pacific. Our members include more than 125,000 individuals and approximately 1,500 provider organizations, nonprofit partners and health services organizations. Our global headquarters is in Rotterdam, The Netherlands, and our Americas headquarters is in Chicago, Illinois. Join our global network at Media Contact: Albe ZakesHIMSS Communications
New Straits Times
an hour ago
- New Straits Times
LyondellBasell to divest four European sites in deal with AEQUITA
KUALA LUMPUR: LyondellBasell (LYB), a leader in the global chemical industry, has entered into an agreement and exclusive negotiations with AEQUITA for the sale of select olefins and polyolefins assets and the associated business in Europe. The sites to be sold have been part of the previously announced European strategic assessment and are located in Berre (France), Münchsmünster (Germany), Carrington (United Kingdom), and Tarragona (Spain). "This contemplated transaction is a significant step in LYB's transformation to grow and upgrade our core. We are committed to operating our assets safely and reliably throughout this process and will continue to support our customers, employees and other key stakeholders. "Europe remains a core market for LYB and one we will continue to participate in following this transaction with more of a focus on value creation through establishing profitable leadership in circular and renewable solutions," said LyondellBasell chief executive officer, Peter Vanacker, in a statement. Meanwhile, AEQUITA managing partner, Christoph Himmel, said the acquisition of these assets from LYB marks another important step in expanding its industrial footprint. Each site brings a strong operational foundation and a highly experienced, committed employee base. The assets and business to be acquired by AEQUITA include integrated and non-integrated sites within LYB's European olefins and polyolefins business, as well as supporting central functions based at the company's Rotterdam headquarters and various locations. The sites together represent a scaled olefins and polyolefins platform strategically located in proximity to a longstanding customer base and with access and connectivity to key infrastructure. The agreement is a put option deed under which AEQUITA has committed to enter into an agreed form purchase agreement if LYB exercises its put option after the conclusion of certain works council consultation processes. Closing of the proposed transaction is currently expected in the first half of 2026, subject to the completion of the information and consultation processes with the relevant employee representative bodies in accordance with applicable laws, as well as regulatory and other customary closing conditions.
The Star
2 hours ago
- The Star
Pan Merchant aims to raise RM67.6mil from IPO
KUALA LUMPUR: Solid-liquid filtration solutions provider Pan Merchant Bhd aims to raise RM67.6 million from its initial public offering (IPO) en route to a listing on the ACE Market of Bursa Malaysia. The company, which is scheduled for the listing on June 26, 2025, is making a public issue of 232.2 million new shares, priced at 27 sen apiece. Managing director Wong Voon Ten said that through this IPO, the group aims to stay ahead in the industry, placing strong emphasis on research and development, sharpening products performance and experimenting with new materials and technologies. He said the group is also pushing ahead with its international expansion strategy, with particular focus on the United State (US) and European markets which represent high-potential opportunities for premium solid-liquid filtration systems. "We are committed to expanding our international footprint and sharpening our competitive edge as we work towards growing our global market share to 2.0 per cent - 3.0 per cent in the future from 0.5 per cent,' he said during the launch of Pan Merchant's prospectus here today. Wong said Pan Merchant is ramping up its manufacturing capabilities by investing in the latest machinery and expanding automation. The company has earmarked 40 per cent for its capital expenditure out of the RM67.6 million listing proceeds. "The proceeds are going to be mainly in purchasing of capital and investment into machinery for more automation in our production processes and including bringing higher efficiencies in the production process itself with robotics and automation in Computer Numerical Control (CNC) machining centres and so on," Wong said.. From RM67.6 million IPO proceeds, RM62.7 million will be accrued to Pan Merchant, while the balance of RM4.9 million will be for the offerer. Of the total proceeds of RM62.7 million raised, RM28 million would be allocated to capital expenditure for manufacturing plants, including the acquisition of machinery, equipment and tools, as well as renovations to its manufacturing facilities, the company said. A further RM7 million will be allocated for product development and RM27.7 million for business expansion, general working capital and defraying of listing expenses. Established for 38 years, the company is also expanding its business into water, mineral processing and mining industries and renewable energies from the hydrotreated vegetable oil industry. It also aims to distribute at least 30 per cent of its net profit to reward shareholders. Affin Hwang Investment Bank is the principal adviser, sponsor, sole placement agent and sole underwriter for Pan Merchant's IPO exercise. - Bernama
